These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17138490)

  • 21. Systematic review: reliability of compendia methods for off-label oncology indications.
    Abernethy AP; Raman G; Balk EM; Hammond JM; Orlando LA; Wheeler JL; Lau J; McCrory DC
    Ann Intern Med; 2009 Mar; 150(5):336-43. PubMed ID: 19221366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatotoxicity and hepatic metabolism of available drugs: current problems and possible solutions in preclinical stages.
    Giri S; Nieber K; Bader A
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):895-917. PubMed ID: 20367107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug effects on the liver: a tabular compilation of drugs and drug-related hepatic diseases.
    Ludwig J
    Dig Dis Sci; 1979 Oct; 24(10):785-96. PubMed ID: 487916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An expert system approach to the assessment of hepatotoxic potential.
    Marchant CA; Fisk L; Note RR; Patel ML; Suárez D
    Chem Biodivers; 2009 Nov; 6(11):2107-14. PubMed ID: 19937847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxicity of nonsteroidal anti-inflammatory drugs.
    Rabinovitz M; Van Thiel DH
    Am J Gastroenterol; 1992 Dec; 87(12):1696-704. PubMed ID: 1449128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antineoplastic agents: comparing off-label uses among authoritative drug compendia.
    Thompson DF; Keefe CC
    Hosp Formul; 1993 Jul; 28(7):641-2, 647. PubMed ID: 10127046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drug-induced hepatotoxicity.
    Aithal GP; Day CP
    Clin Liver Dis; 2007 Aug; 11(3):563-75, vi-vii. PubMed ID: 17723920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review article: drug hepatotoxicity.
    Chang CY; Schiano TD
    Aliment Pharmacol Ther; 2007 May; 25(10):1135-51. PubMed ID: 17451560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of metabolism in drug-induced idiosyncratic hepatotoxicity.
    Walgren JL; Mitchell MD; Thompson DC
    Crit Rev Toxicol; 2005; 35(4):325-61. PubMed ID: 15989140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference.
    Bangalore S; Kumar S; Messerli FH
    Am J Med; 2010 Nov; 123(11):1016-30. PubMed ID: 21035591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ability of online drug databases to assist in clinical decision-making with infectious disease therapies.
    Polen HH; Zapantis A; Clauson KA; Jebrock J; Paris M
    BMC Infect Dis; 2008 Nov; 8():153. PubMed ID: 18990224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver damage and nonsteroidal anti-inflammatory drugs: case non-case study in the French Pharmacovigilance Database].
    Bareille MP; Montastruc JL; Lapeyre-Mestre M
    Therapie; 2001; 56(1):51-5. PubMed ID: 11322018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational chemistry approach for the early detection of drug-induced idiosyncratic liver toxicity.
    Cruz-Monteagudo M; Cordeiro MN; Borges F
    J Comput Chem; 2008 Mar; 29(4):533-49. PubMed ID: 17705164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project.
    de Bie S; Ferrajolo C; Straus SM; Verhamme KM; Bonhoeffer J; Wong IC; Sturkenboom MC;
    PLoS One; 2015; 10(6):e0130399. PubMed ID: 26090678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Various forms of chemically induced liver injury and their detection by diagnostic procedures.
    Zimmerman HJ
    Environ Health Perspect; 1976 Jun; 15():3-12. PubMed ID: 1001294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.
    Aithal GP; Rawlins MD; Day CP
    J Hepatol; 2000 Dec; 33(6):949-52. PubMed ID: 11131457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hepatotoxicity due to drugs or natural products in children].
    Ocete Hita E; Martín García JA; Giménez Sánchez F; Flores González JC; Abril Molina A; Salmerón Escobar J; Ruiz Extremera A
    An Pediatr (Barc); 2013 Apr; 78(4):248-59. PubMed ID: 23017742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between tetracycline or doxycycline and hepatotoxicity: a population based case-control study.
    Heaton PC; Fenwick SR; Brewer DE
    J Clin Pharm Ther; 2007 Oct; 32(5):483-7. PubMed ID: 17875115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatotoxic effects of drugs in childhood (author's transl)].
    Morlán A; Jara P
    An Esp Pediatr; 1982 Jan; 16(1):66-76. PubMed ID: 7081853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.